Navis Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Hold |
3,978
| – | – | 0.51% | 41 |
|
|
2025
Q1 | $626K | Hold |
3,978
| – | – | 0.61% | 38 |
|
|
2024
Q4 | $624K | Buy |
3,978
+31
| +0.8% | +$4.87K | 0.68% | 33 |
|
|
2024
Q3 | $700K | Hold |
3,947
| – | – | 0.76% | 31 |
|
|
2024
Q2 | $665K | Hold |
3,947
| – | – | 0.76% | 29 |
|
|
2024
Q1 | $657K | Hold |
3,947
| – | – | 0.79% | 29 |
|
|
2023
Q4 | $653K | Buy |
3,947
+17
| +0.4% | +$2.81K | 0.85% | 23 |
|
|
2023
Q3 | $612K | Hold |
3,930
| – | – | 0.89% | 21 |
|
|
2023
Q2 | $613K | Hold |
3,930
| – | – | 0.56% | 26 |
|
|
2023
Q1 | $637K | Hold |
3,930
| – | – | 0.7% | 26 |
|
|
2022
Q4 | $628K | Buy |
3,930
+18
| +0.5% | +$2.88K | 0.89% | 24 |
|
|
2022
Q3 | $551K | Hold |
3,912
| – | – | 0.85% | 25 |
|
|
2022
Q2 | $570K | Hold |
3,912
| – | – | 0.61% | 36 |
|
|
2022
Q1 | $634K | Hold |
3,912
| – | – | 0.56% | 44 |
|
|
2021
Q4 | $741K | Buy |
3,912
+8
| +0.2% | +$1.52K | 0.62% | 37 |
|
|
2021
Q3 | $789K | Hold |
3,904
| – | – | 0.55% | 35 |
|
|
2021
Q2 | $787K | Hold |
3,904
| – | – | 0.66% | 37 |
|
|
2021
Q1 | $685K | Buy |
3,904
+1,065
| +38% | +$187K | 0.53% | 38 |
|
|
2020
Q4 | $482K | Buy |
+2,839
| New | +$482K | 0.44% | 50 |
|